Skip to main content
. 2018 Jun 21;73(9):1842–1850. doi: 10.1111/all.13433

Figure 3.

Figure 3

Impact of baseline conjunctival provocation test (CPT) reactivity on CSMSs. Comparison of the mean daily combined symptom and medication score (CSMS) during the peak pollen period (A) and during the entire pollen season (B) in the placebo and Lolium perenne pollen peptides (LPP) groups for the whole population and for the subpopulation of patients with a CPT score of 3 and 4 at baseline. Data are presented as mean ± SEM